Lantu Biopharma
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Lantu Biopharma
RECRUITINGPhase 3NCT07265232
Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle...
The study objective is to determine the real-world safety and effectiveness of Vesemnogene lantuparvovec for the treatment of SMA. The specific objectives are: * To determine...
Sponsor: Lantu BiopharmaEnrolling: 151 location
Spinal Muscular Atrophy (SMA)
RECRUITINGPhase 1 / Phase 2NCT06288230
An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy
This is an interventional study to evaluate safety and efficacy of AAV-hSMN1 in spinal muscular atrophy patients.
Sponsor: Lantu BiopharmaEnrolling: 201 location
Spinal Muscular Atrophy